연구동향 분석

Double cocktail immunostains with high molecular weight cytokeratin and GATA-3: useful stain to discriminate in situ involvement of prostatic ducts or acini from stromal invasion by urothelial carcinoma in the prostate

이정혜 유영은 박상희 조민선 성선희 Jae Y. Ro 2020년

논문상세정보
인용/피인용

' Double cocktail immunostains with high molecular weight cytokeratin and GATA-3: useful stain to discriminate in situ involvement of prostatic ducts or acini from stromal invasion by urothelial carcinoma in the prostate' 의 참고문헌

  • Utility of p63 and high molecular weight cytokeratin in the distinction between urothelial carcinoma with prostatic stromal invasion and urothelial carcinoma with colonisation of prostatic ducts and acini
    Chastain EC [2012]
  • Urothelial carcinoma of the bladder with transmural and direct prostatic stromal invasion : does extent of stromal invasion significantly impact patient outcome
    Oliva IV [2011]
  • Urethral dysplasia and bladder cancer in cystectomy specimens
    Coutts AG [1985]
  • Transitional cell carcinoma of the prostate in patients undergoing radical cystoprostatectomy
    Reese JH [1992]
  • Transitional cell carcinoma of the prostate in cystoprostatectomy specimens removed for bladder cancer
    Wood DP Jr [1989]
  • Transitional cell carcinoma of the prostate
    Bates HR Jr [1969]
  • Transitional cell carcinoma of the prostate
  • Transitional cell carcinoma involving the prostate : a clinicopathological retrospective study of 76 cases
  • The management of transitional cell carcinoma in the prostate
    Wolfe JH [1981]
  • The Expressions of Cytokeratin 7 and 20 in Epithelial Tumors: A Survey of 91 Cases
  • Risk assessment of prostatic pathology in patients undergoing radical cystoprostatectomy
    Pettus JA [2008]
  • Prostatic tumor relapse in patients with superficial bladder tumors : 15-year outcome
    Herr HW [1999]
  • Prostatic involvement by urothelial carcinoma of the bladder : clinicopathological features and outcome after radical cystectomy
  • Prostatic involvement by transitional cell carcinoma in patients with bladder cancer and its prognostic significance
    Shen SS [2006]
  • Prostatic involvement by transitional cell carcinoma : pathogenesis patterns and prognosis
  • Placental S100(S100P)and GATA3 : markers for transitional epithelium and urothelial carcinoma discovered by complementary DNA microarray
    Higgins JP [2007]
  • Is stage pT4a(D1)reliable in assessing transitional cell carcinoma involvement of the prostate in patients with a concurrent bladder cancer? A necessary distinction for contiguous or noncontiguous involvement
    Pagano F [1996]
  • Incidence and location of prostate and urothelial carcinoma in prostates from cystoprostatectomies : implications for possible apical sparing surgery
    Revelo MP [2004]
  • Immunohistochemistry of ductal adenocarcinoma of the prostate and adenocarcinomas of non-prostatic origin : a comparative study
    Seipel AH [2016]
  • Immunohistochemical evaluation of GATA3 expression in tumors and normal tissues : a useful immunomarker for breast and urothelial carcinomas
    Liu H [2012]
  • Immunohistochemical differentiation of high-grade prostate carcinoma from urothelial carcinoma
    Chuang AY [2007]
  • GATA3 expression in benign prostate glands with radiation atypia : a diagnostic pitfall
    Tian W [2017]
  • Differential expression of GATA-3 in urothelial carcinoma variants
    Liang Y [2014]
  • Diagnostic utility of androgen receptor expression in discriminating poorly differentiated urothelial and prostate carcinoma
    Downes MR [2013]
  • Challenges in the pathological reporting of urothelial carcinoma involving prostatic transurethral resection specimens within a single institution
    Perrino CM [2013]
  • CK5, CK5/6, and double-stains CK7/CK5 and p53/CK5 discriminate in situ vs invasive urothelial cancer in the prostate
  • AJCC cancer staging manual
    Amin MB [2017]
  • AJCC cancer staging manual
    Edge SB [2010]